Ascendis Pharma A/S ( (ASND) ) has released its Q3 earnings. Here is a breakdown of the information Ascendis Pharma A/S presented to its ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” third-quarter 2024 investor ...

Fifth Third Bancorp is bucking a trend by not only adding branches in the Southeast but doing it at a faster pace than ...

Fidelity International Capital Appreciation Fund is a diversified international equity strategy that seeks capital growth by ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings. Welcome to the iCAD Incorporated Third Quarter 2024 ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3 - TransCon CNP NDA submission for achondroplasia planned for Q1 2025 ...

Worldwide Healthcare Trust PLC - Half-year Report PR Newswire LONDON, United Kingdom, November 15 LONDON STOCK EXCHANGE ANNOUNCEMENTWorldwide Healthcare Trust PLCUnaudited ...

When Alicia Fivecoat, a mom of two, felt a golf ball-sized mass under her arm late last year, she said she was devastated to ...